semaglutide and thyroid tumors New Research Challenges Fears of Semaglutide-Linked Cancer Risk Ozempic Thyroid Cancer Lawsuit [2026

Variants in GLP-1 receptor, GIPR, FTO, and MC4R genes may correlate with baseline appetite set-point and treatment trajectory, though genetic predisposition does not determine outcome and should be interpreted with qualified medical guidance

Note: ForwardHealth will consider the entire clinical record for the PA request determination decision

The clinical relevance in humans is still unclear, but the current guidance is that retatrutide should not be used in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

The future belongs to oral small molecules that are cheaper, easy to store and ship, combine, produce and administer